Clinical Trial Update: A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma [Phase 2]

View source ↗

Summary

Phase 2 study of DKN-01 as a monotherapy or with paclitaxel in recurrent epithelial endometrial cancer, epithelial ovarian cancer, or carcinosarcoma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• DKN-01 (dkn-01)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Leap Therapeutics, Inc. | Conditions: Endometrial Cancer, Uterine Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-09